The Beat With Joel Dunning Ep. 85: End of an Era in Cardiac Surgery

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning pays tribute to the late-cardiac surgeon Albert Starr. He discusses Dr. Starr’s personal and professional life, his accomplishments, and the Starr-Edwards valve. He also discusses the background of CTSNet, provides a quick statistics review of CTSNet, and the CTSNet career center.   Joel also reviews recent JANS articles on heart surgeons performing the world’s first combined robotic AVR and CABG, the prevalence of invasive lung cancer in pure ground glass nodules less than 30 mm, external validation of EuroSCORE I and II in patients with infective endocarditis, and totally endoscopic coronary artery bypass graft.   In addition, Joel explores robotic-assisted tracheobronchoplasty, spontaneously closed VSD presenting as an Iatrogenic Gerbodie defect, and single leaflet neocuspidization for aortic regurgitation due to infective endocarditis in adult congenital heart disease. Before closing, he highlights upcoming events in CT surgery.   JANS Items Mentioned  1.) Heart Surgeons Perform World’s First Combined Robotic AVR and CABG  2.) Prevalence of Invasive Lung Cancer in Pure Ground Glass Nodules Less Than 30 mm: A Systematic Review  3.) External Validation of EuroSCORE I and II in Patients With Infective Endocarditis: Results From a Nationwide Prospective Registry  4.) Totally Endoscopic Coronary Artery Bypass Graft: Systematic Review and Meta-Analysis of Reconstructed Patient-Level Data  CTSNET Content Mentioned  1.) Robotic-Assisted Tracheobronchoplasty: A Quick Way to Fix the Airway  2.) Spontaneously Closed VSD Presenting as an Iatrogenic Gerbodie Defect  3.) Single Leaflet Neocuspidization for Aortic Regurgitation Due to Infective Endocarditis in Adult Congenital Heart Disease  Other Items Mentioned  CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

There are no comments yet.

Please log in to write the first comment.